The latest UK #biotech investment data collected in collaboration with Clarivate has been published by the UK BioIndustry Association (BIA). Forbion was named the most active non-UK investor in the sector in the BIA’s list of “Top ten VC investors in UK companies by deal count and total invested.” Our Forbion Growth Opportunities Fund II at the first close of €470m was the fourth largest fund raised in 2022 which have mandates allowing investment in UK biotech. Two of Forbion portfolio companies were included in the “Top 10 Venture Deals” – F2G and Pheon Therapeutics.
Access the report here.